The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective hematopoiesis and a wide spectrum of manifestations ranging from indolent and asymptomatic cytopenias to acute myeloid leukemia (AML). MDS result from genetic and epigenetic derangements in clonal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokr, Nora, Patel, Rima, Wattamwar, Kapil, Chokr, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241340/
https://www.ncbi.nlm.nih.gov/pubmed/30519261
http://dx.doi.org/10.1155/2018/2458679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241340/
https://www.ncbi.nlm.nih.gov/pubmed/30519261
http://dx.doi.org/10.1155/2018/2458679

Ejemplares similares